Summary

Atrial arrhythmia is the most frequent cardiac arrhythmia. It is a source of significant morbidity.

Hypertension is a major risk factor for atrial arrhythmias. Primary hyperaldosteronism (PA) is a common cause of secondary hypertension, associated with a high prevalence of arrhythmias with a specific, sometimes curative, treatment. The purpose of the study is to show that the prevalence of PA among hypertensive patients under 65 years old with atrial arrhythmia is high, justifying systematic screening.

Study Name: Prevalence of Primary Aldosteronism Among Hypertensive Patients With Atrial Arythmia (HAPAA)
Status: Recruiting
Conditions: Primary aldosteronism, Atrial Fibrillation
Interventions: Diagnostic Test: Primary Hyperaldosteronism diagnostic
Locations: CHU de Bordeaux, Bordeaux, France; CH de Pau, PAU, France
Study link: https://clinicaltrials.gov/ct2/show/NCT04115280

To search for other studies by topic, location, or status, go to our Clinical Studies page.

©2021 Primary Aldosteronism Foundation — All Rights Reserved

The Primary Aldosteronism Foundation is a registered 501(c)(3) public charity. Donations are tax deductible in the US.

©2021 Primary Aldosteronism Foundation

The Primary Aldosteronism Foundation is a registered 501(c)(3) public charity. Donations are tax deductible in the US.